Financings Of The Fortnight: In The Aftermath Of Facebook IPO, Kythera Steps Up, TVAX And Cancer Genetics Back Off
This article was originally published in The Pink Sheet Daily
Executive Summary
Plus news on recent financing activity by TVM Capital, Royalty Pharma, Prosonix and Sangart.